At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...